Date of Award
6-1-2017
Document Type
Open Access Thesis
Degree Name
Master of Medical Science (MMSc)
First Advisor
Suguru Imaeda, MD
Abstract
Actinic keratoses are common premalignant lesions that occur in fair-skinned individuals with high cumulative ultraviolet exposure. Monotherapy with ingenol mebutate has been known to cause local skin reactions, such as erythema, which reduces safety. Clobetasol propionate has worked well with other actinic keratosis therapies to reduce inflammation, but its role with ingenol mebutate is not well understood. The effect of concurrent application of clobetasol propionate with ingenol mebutate to reduce local skin reactions without impacting efficacy has not yet been investigated. We are proposing a superiority trial for safety as well as a non-inferiority trial for effectiveness. We will conduct an intra-individual, randomized controlled trial at the West Haven Veterans Affairs in patients with multiple actinic keratoses, and analyze local skin reactions at day 4 and efficacy at day 57. If combination therapy has significant advantages compared to monotherapy, it can improve the safety profile and tolerability of ingenol mebutate.
Recommended Citation
Amin, Shreya, "Effect of Corticosteroid on Safety and Efficacy for Actinic Keratosis Therapy with Ingenol Mebutate" (2017). Yale School of Medicine Physician Associate Program Theses. 40.
https://elischolar.library.yale.edu/ysmpa_theses/40
